Related references
Note: Only part of the references are listed.Insulin resistance/hyperinsulinemia and cancer mortality: the Cremona study at the 15th year of follow-up
Gianluca Perseghin et al.
ACTA DIABETOLOGICA (2012)
Cancer Statistics, 2012
Rebecca Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2012)
Steps Toward the Meaningful Translation of Prevention Strategies for Type 2 Diabetes
William T. Cefalu
DIABETES CARE (2012)
Prevalence of diabetes mellitus secondary to pancreatic diseases (type 3c)
N. Ewald et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2012)
Association of an Intensive Lifestyle Intervention With Remission of Type 2 Diabetes
Edward W. Gregg et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2012)
Diabetes mellitus correlates with increased risk of pancreatic cancer: A population-based cohort study in Taiwan
Kuan-Fu Liao et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2012)
Diabetes and pancreatic cancer
Donghui Li
MOLECULAR CARCINOGENESIS (2012)
PDX-1 Demonstration of Oncogenic Properties in Pancreatic Cancer
Shi-He Liu et al.
CANCER (2011)
Pancreatitis, Pancreatic, and Thyroid Cancer With Glucagon-Like Peptide-1-Based Therapies
Michael Elashoff et al.
GASTROENTEROLOGY (2011)
Diabetes Mellitus, Fasting Glucose, and Risk of Cause-Specific Death
Sreenivasa Rao Kondapally Seshasai et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Pancreatogenic Diabetes: Special Considerations for Management
YunFeng Cui et al.
PANCREATOLOGY (2011)
Past Medical History and Pancreatic Cancer Risk: Results From a Multicenter Case-Control Study
Patrick Maisonneuve et al.
ANNALS OF EPIDEMIOLOGY (2010)
Diabetes and Cancer: A Consensus Report
Edward Giovannucci et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2010)
Body mass index, effect modifiers, and risk of pancreatic cancer: a pooled study of seven prospective cohorts
Li Jiao et al.
CANCER CAUSES & CONTROL (2010)
Metabolic Factors and the Risk of Pancreatic Cancer: A Prospective Analysis of almost 580,000 Men and Women in the Metabolic Syndrome and Cancer Project
Dorthe Johansen et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2010)
Crosstalk between Insulin/Insulin-like Growth Factor-1 Receptors and G Protein-Coupled Receptor Signaling Systems: A Novel Target for the Antidiabetic Drug Metformin in Pancreatic Cancer
Enrique Rozengurt et al.
CLINICAL CANCER RESEARCH (2010)
Pancreatic duct replication is increased with obesity and type 2 diabetes in humans
A. E. Butler et al.
DIABETOLOGIA (2010)
Obesity: Focus on all-cause mortality and cancer
Birgit Teucher et al.
MATURITAS (2010)
Context-Dependent Transformation of Adult Pancreatic Cells by Oncogenic K-Ras
Sharon Y. Gidekel Friedlander et al.
CANCER CELL (2009)
New Users of Metformin Are at Low Risk of Incident Cancer A cohort study among people with type 2 diabetes
Gillian Libby et al.
DIABETES CARE (2009)
Antidiabetic Therapies Affect Risk of Pancreatic Cancer
Donghui Li et al.
GASTROENTEROLOGY (2009)
New-onset diabetes: a potential clue to the early diagnosis of pancreatic cancer
Rahul Pannala et al.
LANCET ONCOLOGY (2009)
Medical Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy A consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes
David M. Nathan et al.
DIABETES CARE (2009)
Rosiglitazone no longer recommended
[Anonymous]
LANCET (2008)
Prevalence and clinical profile of pancreatic cancer-associated diabetes mellitus
Rahul Pannala et al.
GASTROENTEROLOGY (2008)
Pancreatic cancer-associated diabetes mellitus: Prevalence and temporal association with diagnosis of cancer
Suresh T. Chari et al.
GASTROENTEROLOGY (2008)
Insulin and insulin-like growth factor signalling in neoplasia
Michael Pollak
NATURE REVIEWS CANCER (2008)
Metformin inhibits mammalian target of rapamycin-dependent translation initiation in breast cancer cells
Ryan J. O. Dowling et al.
CANCER RESEARCH (2007)
Chronic pancreatitis is essential for induction of pancreatic ductal adenocarcinorna by k-Ras Oncogenes in adult mice
Carmen Guerra et al.
CANCER CELL (2007)
Increased cancer-related mortality for patients with type 2 diabetes who use sulforrylureas or insulin
SL Bowker et al.
DIABETES CARE (2006)
Insulin, glucose, insulin resistance, and pancreatic cancer in male smokers
RZ Stolzenberg-Solomon et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin
RJ Shaw et al.
SCIENCE (2005)
Type-II diabetes and pancreatic cancer:: a meta-analysis of 36 studies
R Huxley et al.
BRITISH JOURNAL OF CANCER (2005)
Diabetes status and post-load plasma glucose concentration in relation to site-specific cancer mortality: findings from the original Whitehall study
GD Batty et al.
CANCER CAUSES & CONTROL (2004)
Exocrine pancreatic cancer, cigarette smoking, and diabetes mellitus: A case-control study in Northern Italy
L Bonelli et al.
PANCREAS (2003)
Overweight, obesity, and mortality from cancer in a prospectively studied cohort of US adults
EE Calle et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes
AE Butler et al.
DIABETES (2003)
Physical activity, obesity, height, and the risk of pancreatic cancer
DS Michaud et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
Physiological concentrations of insulin augment pancreatic cancer cell proliferation and glucose utilization by activating MAP kinase, PI3 kinase and enhancing GLUT-1 expression
XZ Ding et al.
PANCREAS (2000)